As the use of biosimilars continues to grow within the healthcare industry, it’s important to understand and implement best practices to ensure successful and smooth integration. In a recent Pharmacy Times article, Derek Burns, Pharm.D., MBA, BCPS, BCSCP and Lisa Lasita highlight key operational, clinical and reimbursement insights to consider when integrating biosimilars into practices, specifically for retina and neurology. Read the article here: https://lnkd.in/gQf6Q2Z6
About us
Welcome to the official LinkedIn page for McKesson Corporation. We're an impact-driven healthcare organization dedicated to “Advancing Health Outcomes For All.” As a global healthcare company, we touch virtually every aspect of health. Our leaders empower our people to lead with a growth mindset and deliver excellence for our customers, partners, and the wellbeing of people, everywhere. We work with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services that make quality care more accessible and affordable. Delivering better health outcomes for our employees, our communities, and our environment. Every day, we strive to inspire and enable people to reach their full potential. To learn more about how #TeamMckesson helps improve care in every setting, visit: https://bit.ly/3xadvB0
- Website
-
https://bit.ly/3xadvB0
External link for McKesson
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Irving, Texas
- Type
- Public Company
- Specialties
- Pharmaceutical Distribution, HealthCare IT, Practice Management, Supply Chain Management, Medication Adherence, Pharmacy Management, Medical Supplies, Oncology Medicine, and Pharmacy Technology
Locations
Employees at McKesson
-
Daniel Tedesco
Managing Principal Counsel, Artificial Intelligence, Enterprise Technology & Sourcing Transactions at McKesson
-
Mark Haynes
Email Marketing Specialist
-
Cassandra L. Wilson
Program Manager - Radiation Value-Based Care at McKesson
-
David Smith, MBA
Senior Internal Auditor SOX McKesson
Updates
-
Biologics by McKesson is our specialty pharmacy business that specializes in cancer and rare disease areas with the goal of simplifying access to therapies. We have What it Takes to deliver personalized care so patients understand how to take medications, manage side effects and achieve the best possible outcomes. Learn more: https://bit.ly/3EErc4x
-
A recently published STAT article from #ASH24 highlighted our efforts with The US Oncology Network to advance the practice of precision medicine within community oncology, from improving local access to clinical trials to making research more inclusive. Read more about improving local access to advanced care: https://lnkd.in/g9cwMx5a
-
With innovative tools, efficient processes, integrated delivery networks and strong relationships across the country, our U.S. Pharmaceutical businesses help to make sure customers get the therapies patients need – anytime, anywhere. Learn more: https://bit.ly/4b2CX0D
-
In order for medicines to reach the hands of patients, products have to go through a complex, secure and reliable supply chain. This supply chain links 1,400 manufacturers to over 330,000 care sites, and delivers approximately 11 million products daily. Learn more from Gene Cavacini, senior vice president and chief operating officer of U.S. Pharmaceutical, in Healthcare Business Today. https://lnkd.in/gRkmBwXu
-
Outpatient oncology practices must remain agile when it comes to meeting United States Pharmacopeia compliance standards. In a recent Pharmacy Times article, Derek Burns, Pharm.D., MBA, BCPS, BCSCP, shares cost-effective initiatives outpatient oncology practices can implement to help reach compliance goals and, ultimately, maintain the safety of patients and employees within healthcare settings. Read more: https://lnkd.in/gxe8X2QM
-
We're celebrating members of our Black Excellence (BE) employee resource group (ERG) and the impact they're making within our company and our communities. Learn about two BE leaders whose involvement with the ERG has helped them connect with their cultural roots and give back through philanthropic work. https://bit.ly/42CubnN
-
Today we announced a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC, a premier provider of general ophthalmology and retina management services. Welcoming PRISM Vision to McKesson reinforces our dedication to empowering community-based providers to thrive and deliver outstanding and affordable patient care in their local communities in today’s rapidly evolving healthcare landscape. Learn more: https://bit.ly/3CEHaef
-
Time and temperature are critical factors of healthcare logistics. From inbound receipt and warehousing to outbound delivery, at McKesson Third Party Logistics℠, our cold chain solutions maintain the integrity and efficacy of your products. Our state-of-the-art facilities and real-time monitoring systems provide unparalleled assurance, minimizing risk and streamlining access for patients. Learn more about our offerings: https://bit.ly/4hDySlF
Affiliated pages
Similar pages
Browse jobs
Stock
MCK
NYSE
20 minutes delay
$593.29
-9.18 (-1.524%)
- Open
- 600.66
- Low
- 593.27
- High
- 602.78
Data from Refinitiv
See more info on